Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients
Nothing to Lose: Risk, biases, and communication in cancer care
Indian context and geriatric oncology
Choosing Wisely in endometrial & cervix cancers: BMC data
Choosing Wisely in endometrial & cervix cancers: Surgery
Choosing Wisely in endometrial & cervix cancers: Medical therapy
Selecting patients wisely for neoadjuvant therapy in HPB cancers
Reducing drug expenditures without harming patients
How to ask the right question in an Indian context
Weaving in Choosing Wisely, Common Sense Oncology in all aspects of global health
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer